WallStSmart
SVRA

Savara Inc

NASDAQ: SVRA · HEALTHCARE · BIOTECHNOLOGY

$5.12
-3.96% today

Updated 2026-06-05

Market cap
$1.23B
P/E ratio
P/S ratio
145,272.62x
EPS (TTM)
$-0.56
Dividend yield
52W range
$2 – $7
Volume
1.5M

Savara Inc (SVRA) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$500000.00$500000.00$300000.00$488959.00$0.00$0.00$0.00$1548.00$54.00$400000.00$0.00$0.00$0.00$257000.00$1000.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)+0.0%-40.0%+63.0%-100.0%-96.5%+740640.7%-100.0%-99.6%-100.0%
Cost of revenue$0.00$0.00$0.00$0.00$146000.00$8.18M$363000.00$526000.00$38.78M$35.04M$28.99M$27.88M$44.26M$78.03M$245000.00
Gross profit$500000.00$500000.00$300000.00$488959.00$0.00$0.00$0.00$1548.00$-145946.00$400000.00$-363000.00$-526000.00$-38.78M$-34.78M$-28.99M$-27.88M$-44.26M$-78.03M$-245000.00
Gross margin100.0%100.0%100.0%100.0%100.0%-270270.4%100.0%-13533.5%-2899100.0%
R&D$12.00M$15.93M$17.92M$6.51M$3.69M$5.76M$8.09M$12.90M$19.43M$28.26M$8.18M$18.51M$37.17M$38.78M$35.04M$28.99M$27.88M$44.26M$78.03M$81.40M
SG&A$7.24M$8.68M$9.72M$5.00M$5.32M$7.60M$7.52M$8.52M$9.49M$10.96M$2.82M$11.08M$10.65M$12.86M$11.96M$12.35M$10.93M$15.67M$25.04M$42.06M
Operating income$-29.84M$-24.31M$-27.31M$-11.29M$-8.54M$-13.40M$-15.63M$-21.54M$-29.28M$-39.37M$-10.95M$-29.96M$-70.05M$-79.03M$-49.30M$-41.48M$-38.84M$-60.01M$-103.20M$-123.55M
Operating margin-4862.2%-5462.0%-3761.9%-1746.5%-1891408.3%-72912963.0%-2737.0%-19182.9%-4147700.0%
EBITDA$-29.16M$-24.11M$-27.14M$-11.21M$-8.43M$-13.22M$-15.47M$-21.44M$-28.62M$-39.09M$-10.48M$-31.91M$-69.50M$-50.43M$-45.85M$-40.50M$-38.01M$-59.13M$-102.27M$-118.59M
EBITDA margin-4822.7%-5428.4%-3735.3%-1724.0%-1848643.4%-72394444.4%-2620.5%-17841.2%-4049700.0%
EBIT$-29.33M$-24.31M$-27.31M$-11.29M$-8.45M$-13.26M$-15.56M$-21.48M$-28.70M$-39.24M$-10.83M$-32.27M$-70.03M$-50.74M$-46.11M$-40.63M$-38.04M$-59.21M$-102.40M$-118.84M
Interest expense$0.00$0.00$0.00$0.00$1629.00$11010.00$0.00$0.00$0.00$603000.00$468000.00$1.16M$11000.00$70000.00$1.48M$2.28M$88000.00
Income tax$9.92M$39373.00$-88775.00$-65623.00$-5047.00$-1352.00$-306000.00$473000.00$-357000.00$-3.63M$-8.51M$26.85M$1.48M$2.28M$796000.00$797000.00
Effective tax rate-51.1%0.0%0.0%-0.3%1.0%0.5%0.0%0.0%1.1%-1.2%3.2%10.9%12.2%-52.3%-3.1%-5.6%-2.1%-1.5%0.0%0.0%
Net income$-29.33M$-22.14M$-26.65M$-11.33M$-8.45M$-13.26M$-15.56M$-21.48M$-28.70M$-39.84M$-10.92M$-29.80M$-61.52M$-78.17M$-49.62M$-43.01M$-38.15M$-54.70M$-95.88M$-118.84M
Net income growth (YoY)+24.5%-20.3%+57.5%+25.4%-56.9%-17.3%-38.1%-33.6%-38.8%+72.6%-172.8%-106.5%-27.1%+36.5%+13.3%+11.3%-43.4%-75.3%-23.9%
Profit margin-4428.4%-5329.5%-3775.0%-1728.3%-1854134.4%-73781481.5%-2730.8%-19305.4%-4301400.0%

Frequently asked questions

What is Savara Inc's revenue?

Savara Inc's trailing twelve-month revenue is $1000.00. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How much free cash flow does SVRA generate?

SVRA produced $-101.06M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is SVRA's balance sheet healthy?

SVRA holds $33.18M in cash and equivalents against $29.91M in long-term debt, on $203.13M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.